Skip to main content

Table 2 Changes in mean RV GLS, RV FAC and RV FWS at baseline to follow-up period from pre- to post-doxorubicin therapy at 6-month follow-up

From: Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction

N = 35

Pre

Post

P-value

LVEF (%)

63.3 ± 6.2

61.6 ± 11.1

0.37

RV GLS

−22.4 ± 1.4

−20.6 ± 3.4

0.01

RV FAC (%)

47.3 ± 4.4

43.7 ± 3.9

0.01

RV FWS

−24.9 ± 3.3

−22.2 ± 2.9

0.01

  1. LVEF Left ventricular ejection fraction, RVFAC Right ventricular fractional area change, RVFWS Right ventricular free wall strain, RVGLS Right ventricular global longitudinal strain
Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us